Hepatitis A vaccine inactivated - Sinovac Biotech

Drug Profile

Hepatitis A vaccine inactivated - Sinovac Biotech

Alternative Names: Healive

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sinovac Biotech
  • Class Hepatitis A vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatitis A

Most Recent Events

  • 03 Jun 2015 No recent reports of development identified - Phase-III for Hepatitis A in Ukraine (IM)
  • 21 May 2014 Registered for Hepatitis A in Chile (IM)
  • 28 Feb 2014 Launched for Hepatitis A in Mongolia (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top